Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2017
Title: Abelardo Silva Junior: Innovator in Vaccine Development
Introduction
Abelardo Silva Junior is a notable inventor based in Viçosa, Brazil. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for swine. His innovative work focuses on combating diseases associated with porcine circovirus 2 (PCV-2).
Latest Patents
Abelardo Silva Junior holds a patent for "Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof." This invention pertains to the preparation of recombinant antigens derived from the viral capsid of PCV-2. The process involves expression in a prokaryotic system, purification in monomer form, and recovery of virus-like particles (VLPs). These antigens are utilized in vaccine formulations and diagnostic kits, providing alternatives to existing commercial vaccines. Additionally, the ELISA kit developed can assess the quality of both commercial and experimental vaccines against PCV-2.
Career Highlights
Throughout his career, Silva Junior has been associated with prominent institutions such as the Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and the Universidade Federal de Viçosa. His work has been instrumental in advancing research and development in veterinary immunology.
Collaborations
He has collaborated with notable colleagues, including Márcia Rogéria De Almeida and Juliana Lopes Rangel Fietto, contributing to various research projects aimed at improving animal health.
Conclusion
Abelardo Silva Junior's innovative contributions to vaccine development for swine highlight his commitment to advancing veterinary medicine. His work not only addresses critical health issues in swine breeding but also offers valuable alternatives to existing solutions.